Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, OX1 3QX, United Kingdom.
Adv Drug Deliv Rev. 2013 Mar;65(3):391-7. doi: 10.1016/j.addr.2012.08.008. Epub 2012 Aug 18.
Using oligonucleotide-based drugs to modulate gene expression has opened a new avenue for drug discovery. In particular small interfering RNAs (siRNAs) are being rapidly recognized as promising therapeutic tools, but their poor bioavailability limits the full realization of their clinical potential. In recent years, cumulating evidence has emerged for the role of membrane vesicles, secreted by most cells and found in all body fluids, as key mediators of information transmission between cells. Importantly, a sub-group of these termed exosomes, have recently been shown to contain various RNA species and to mediate their horizontal transfer to neighbouring- or distant recipient cells. Here, we provide a brief overview on membrane vesicles and their role in exchange of genetic information. We also describe how these natural carriers of genetic material can be harnessed to overcome the obstacle of poor delivery and allow efficient systemic delivery of exogenous siRNA across biological barriers such as the blood-brain barrier.
利用基于寡核苷酸的药物来调节基因表达为药物发现开辟了新途径。特别是小干扰 RNA(siRNA)正迅速被视为有前途的治疗工具,但它们的生物利用度差限制了它们在临床上的全部潜力。近年来,越来越多的证据表明,大多数细胞分泌的膜囊泡作为细胞间信息传递的关键介质。重要的是,这些囊泡中的一个亚群最近被证明含有各种 RNA 种类,并介导其横向转移到邻近或远处的受体细胞。在这里,我们简要概述了膜囊泡及其在遗传信息交换中的作用。我们还描述了如何利用这些天然遗传物质载体来克服递送效率差的障碍,以及如何允许外源性 siRNA 高效地通过血脑屏障等生物屏障进行系统递送。